Keratoacanthoma treated with systemic methotrexate. Report of five cases with a short literature review of treatment modalities

Nouvelles Dermatologiques

Volumn 15, Issue 8, 1996, Pages 559-563

  Szepietowski, J ^a   Wasik, F ^a  

^a WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

keratoacanthoma; methotrexate

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; KERATOACANTHOMA; MALE;

EID: 0029830488     PISSN: 07525370     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Dupont A Kyste sebacé atypique. Bull. Soc. Belge Dermatol. 1930; 177-179
2. Musso L , Gordon H., Spontaneous resolution of molluscum sebaceum (keratoacanthoma). Proc. R. Soc. Med. 1950; 43 838-839.
3. Wong WYL., Kolbusz RV , Goldberg LH. Treatment of a recurrent keratoacanthoma with oral isotretinoin. Int. J. Dermatol. 1994; 33: 579-583
4. Schwartz RA. The keratoacanthoma: a review. J Surg. Oncol. 1979; 12: 305-317.
5. Cloudy A., Thivolet J. Multiple keratoacanthoma: association with deficient cell-mediated immunity. Br. J. Dermatol 1975; 93: 593-595.
6. Sina B., Adrian RM. Multiple keratoacanthomas possibly induced by psoralens and ultraviolet A photochemiotherapy. J. Am Acad Dermatol. 1983; 9: 686-688.
7. Ghadially FN. A comparative morphological study of the keratoacanthoma of man and similar experimentaly produced lesions in the rabit J Pathol. Bacterial. 1958; 75. 441-453.
8. Trowell HE. Human papillomavirus associated with keratoacanthoma in Australian patients. Arch. Dermatol 1990; 124: 1654-1655
9. Ghadially F., Barton B., Kerridge D The etiology of keratoacanthoma. Cancer 1963; 16: 603-611.
10. Melton JL, Nelson BR., Stough DB., Brown MD. et al Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad. Dermatol 1991, 25: 1017-1023
11. Heid E., Grosshans E., Lazrak B., Ben Yahia D Keratoacanthoma centrifugum marginatum. Ann. Dermatol. Venereol. 1990, 9: 650-652
12. Mc Glashan JA., Rees G., Bowdler DA , Solitary keratoacanthoma of the nasal vestibule. J. Loryngol. Otol. 1991; 105: 306-308.
13. Cohen N., Plaschkes Y., Pevzner S., Lowenthal M. Review of 57 cases of keratoacanthoma. Plast. Reconstr. Surg. 1972; 49: 138-142
14. Iverson RE., Vistnes LM. Keratoacanthoma is frequently a dangerous diagnosis. Am. J. Surg. 1973; 126. 359-365
15. Jesunas KP. Keratoacanthoma: facial lesion requiring radical excision South. Med. J. 1975; 68: 1116-1119.
16. Boynton JR., Searl SS., Caldwell EH. Large periocular keratoacanthoma. a case for definitive treatment. Ophtalmic Surg 1986; 17 565-569
17. Larson PO. Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery). A review of 43 cases. J. Am. Acad. Dermatol. 1987; 16: 1040-1044
18. Neumann RA , Knobler RM. Argon loser treatment of small keratoacanthomas in difficult locations. Int. J Dermatol. 1990; 29: 733-736.
19. Reymann F. Treatment of keratoacanthomas with currettage Dermatologica. 1977; 155: 90-96
20. Nedwich JA. Evaluation of curettage and electrodesication in treatment of keratoacanthoma. Australas. J Dermatol. 1991; 32: 137-141
21. Shimm DS., Duttenhaver JR., DoucetteJ., Wang CC Radiation therapy of keratoacanthoma. Int. J Radiat. Oncol Biol. Phys. 1983; 9: 759-761.
22. Caccialanza M., Sopelana N. Radiation therapy of keratoacanthomas. results in 55 patients, Int J. Rad. Oncol. Biol. Phys. 1989; 16: 475-477.
23. Donahue B , Cooper JS., Rush S. Treatment of aggressive keratoacanthomas by radiotherapy J. Am. Acad. Dermatol. 1990, 23 489-493.
24. Odom RB. Keratoacanthoma. J. Assoc. Milit. Dermatol 1980, 6: 2-5.
25. Kestel JL., Blair DS Keratoacanthoma treated with methotrexate. Arch. Dermatol 1973; 108: 723-724
26. Tarnowski WM. Multiple keratoacanthoma. Response of a case to systemic chemotherapy. Arch. Dermatol. 1960; 94: 74-80.
27. Benoldi D , Alinovi A. Multiple persistent keratoacanthomas: treatment with oral etretinate J. Am. Acad Dermatol. 1984; 10 1035-1038.
28. Foschini MP., Magnani P , Marconi F , Cook MG. et al. Multiple keratoacanthomas: a case report with evidence of regression with thymic hormone. Br. J. Dermatol. 1991, 124: 479-482.
29. McNairy DJ. Intradermal triamcinolone therapy of keratoacanthoma. Arch. Dermatol. 1964; 89: 136-140
30. Sayama S , Tagami H., Treatment of keratoacanthoma with intralesional bleomycin. Br. J. Dermatol. 1983; 109: 449-452
31. Wickramasinghe L., Hindson TC , Wacks H. Treatment of neoplastic skin lesions with intralesional interferon. J. Am Acad Dermatol. 1989, 20:71-74.
32. Benzerara N , Guennoc B., Balme B., Combemale P. Giant keratoacanthoma. advantage of intralesional methotrexate. Nouv. Dermatol. 1995; 14. 36-38.
33. Goette DK , Odom RB. Successful treatment keratoacanthoma with intralesional fluorouracil. J. Am Acad. Dermatol 1980; 2: 212-216
34. Goette DK. Treatment of keratoacanthoma with topical fluorouracil. Arch. Dermatol. 1983, 119: 951-953
35. Cipollaro VA. The use of podophyllin in the treatment of keratoacanthoma. Int J Dermatol. 1983; 22: 436-440.
36. Kingman J , Callen JP. Keratoacanthoma A clinical study. Arch Dermatol. 1984; 120: 736-740
37. White JE Methotrexate inhibition of deoxyuridme incorporation in the skin of three day old rats. J. Invest. Dermatol 1971; 56 294-297
38. Prutkin L. An ultrastructural study of the keratoacanthoma treated with methotrexate and 5-fluorouracil. Dermatologica 1968; 137 373-380.